Supplements and eye health
2 May 2005
Volume 06, Issue 2
Reviewing the evidence for the role of supplements in eye health, particularly cataract and age-related macular degeneration (AMD).
Abstract
This article reviews the evidence for the role of supplements in eye health, particularly cataract and age-related macular degeneration (ARMD). The possibility that food supplements can delay the development of cataract and/or ARMD is attractive. Published data support an inverse association between intakes of antioxidant nutrients, supplements of vitamin C and multivitamins and cataract, but evidence for ARMD is weaker. Intervention trials have so far yielded limited evidence of benefit for antioxidant supplementation in cataract, although there is some evidence that zinc with or without antioxidants may delay the development of advanced ARMD. Carotenoids, particularly lutein and zeaxanthin, are the most promising nutrients for eye health and preliminary evidence suggests that high dietary intake of lutein may protect against cataract and ARMD. Small intervention trials also suggest that lutein supplements may improve visual function in both conditions. However, further investigation is required to clarify the role of food supplements in the development and treatment of eye disease.
Sign in to view the article
Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Related further reading
A glance at what’s happening in the world of technology - Spring 2023.
As age-related macular degeneration progresses, part of the visual cortex starts to atrophy. But which way does the causal relationship work, asks Kim Thomas, and what does it mean for treatments focused on the retina if the brain has entered an irreversible decline?
The effort, cost and logistics of managing treatment for eye conditions can have a big impact on patients’ quality of life. What can be done to minimise their treatment burden?